Lite Strategy, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $30.3M
- Price
- $0.8902
- % Change (Daily % change from the live per-ticker quote feed.)
- +0.42%
- Volume
- 61.7K
About
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
Quick stats
Shares outstanding34.0M
Computed float33.0M
Float / shares97.1%
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001262104
Websitehttps://www.litestrategy.com
AI Summary
AI-generated1/5
majorbullishbuyback
Lite Strategy Repurchases 13% of Outstanding Shares Since December, Increasing Litecoin Backing Per Share
Lite Strategy has repurchased approximately 4.9 million shares, or 13% of its outstanding common stock, since December 2025 at an average price of $1.11 per share.
The $5.4 million program was funded entirely through treasury operations using Litecoin sales and covered call premiums, successfully narrowing the net asset value discount to below 25% from the low 40% range.
As of July 17, the company holds 819,070 LTC against roughly 31.9 million shares outstanding, maintaining a debt-free balance sheet with preliminary year-end cash of $5.7 million.
Red flags
- Financials for the fourth quarter and full year ended June 30, 2026 are preliminary and unaudited; reliance on share counts and NAV data subject to change.